Aromatase inhibitors block an enzyme that converts androgens into estrogen, primarily used in postmenopausal women with hormone receptor-positive breast cancer. By lowering estrogen levels, they help slow or stop tumor growth. These medications are often prescribed after surgery or alongside other treatments to reduce cancer recurrence risk.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends